Log In
Print
BCIQ
Print
Print this Print this
 

GLP-1 agonist

  Manage Alerts
Collapse Summary General Information
Company Heptares Therapeutics Ltd.
DescriptionOral once-daily glucagon-like peptide-1 (GLP-1) agonist
Molecular Target Glucagon-like peptide-1 (GLP-1)
Mechanism of ActionGlucagon receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today